150 credits of which 90 credits in biomedicine, pharmaceutical science, natural science and/or technology. Prior studies should include 10 credits in chemistry and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
The course deals with different phases in drug development; identification and validation of target molecule (the target), identification and optimisation of active substance, ADME-Tox profiling, in-vivo and in-vitro pharmacology, formulation, discovery and biomarkers and disease models, clinical trials, registration and commercialisation.
